Literature DB >> 15463703

Merozoite surface antigen-I of plasmodium.

J A Cooper1.   

Abstract

The merozoite is the invasive form of the asexual stage of Plasmodium species. At least two polymorphic glycoproteins have been found on its surface in the human malaria parasite Plasmodium falciparum. The best-characterized of these is known as merozoite surface antigen-1 (MSA1) (185-200 kDa) (Ref. 1). Similar molecules are found in other malaria species. The other merozoite surface antigen, MSA2 (35-48 kDa) (Ref. 2), is distinct from MSA1 but is equally polymorphic. In this review, Juan Cooper condenses the body of structural information on MSA1 known to date. A database compiled from MSA1 sequences from several species used together with sequence comparisons and predicted secondary structure reveals interesting features of this molecule.

Entities:  

Year:  1993        PMID： 15463703     DOI： 10.1016/0169-4758(93)90031-a

Source DB:  PubMed          Journal:  Parasitol Today        ISSN： 0169-4758


  23 in total

1.  Imbalanced distribution of Plasmodium falciparum MSP-1 genotypes related to sickle-cell trait.

Authors:  F Ntoumi; C Rogier; A Dieye; J F Trape; P Millet; O Mercereau-Puijalon
Journal:  Mol Med       Date:  1997-09       Impact factor: 6.354

2.  Oral vaccination of mice against rodent malaria with recombinant Lactococcus lactis expressing MSP-1(19).

Authors:  Zhi-Hong Zhang; Pei-Hong Jiang; Ning-Jun Li; Mi Shi; Weida Huang
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

3.  A multigene family that interacts with the amino terminus of plasmodium MSP-1 identified using the yeast two-hybrid system.

Authors:  Kerrianne Mello; Thomas M Daly; Joanne Morrisey; Akhil B Vaidya; Carole A Long; Lawrence W Bergman
Journal:  Eukaryot Cell       Date:  2002-12

Review 4.  Current status of malaria and potential for control.

Authors:  R S Phillips
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

5.  High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria.

Authors:  C Aucan; Y Traoré; F Tall; B Nacro; T Traoré-Leroux; F Fumoux; P Rihet
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Detection of Plasmodium falciparum, P. vivax, P. ovale, and P. malariae merozoite surface protein 1-p19 antibodies in human malaria patients and experimentally infected nonhuman primates.

Authors:  A Scott Muerhoff; Larry G Birkenmeyer; Ruthie Coffey; Bruce J Dille; John W Barnwell; William E Collins; Joann S Sullivan; George J Dawson; Suresh M Desai
Journal:  Clin Vaccine Immunol       Date:  2010-08-11

7.  Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli.

Authors:  S Dutta; L A Ware; A Barbosa; C F Ockenhouse; D E Lanar
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

8.  Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli.

Authors:  Suraksha Sachdeva; Gul Ahmad; Pawan Malhotra; Paushali Mukherjee; V S Chauhan
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Pathways for potentiation of immunogenicity during adjuvant-assisted immunizations with Plasmodium falciparum major merozoite surface protein 1.

Authors:  G S Hui; C N Hashimoto
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  Primary structure of the variable region of monoclonal antibody 2B10, capable of inducing anti-idiotypic antibodies that recognize the C-terminal region of MSA-1 of Plasmodium falciparum.

Authors:  S Su; S Yang; R Ding; E A Davidson
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.